22nd EUFEPS Talks

We want to invite you to the 22nd EUFEPS Talks on May 19, 2025 at 4 pm CEST.

Twan Lammers will give a talk with the title: "Smart Strategies to Promote Cancer Nanomedicine Performance and Clinical Translation".

Abstract:

Nanomedicines are extensively used for cancer therapy. By delivering drug molecules more effectively and more selectively to pathological sites, nanomedicines assist in improving the balance between drug efficacy and toxicity. The tumor accumulation of nanomedicines is traditionally ascribed to the EPR effect, which is highly variable, both in animal models and in patients. To address issues associated with tumor targeting heterogeneity, and to advance cancer nanomedicine clinical translation, we are working on systems and strategies to monitor and modulate tumor-targeted drug delivery. In the present lecture, several of these strategies will be highlighted, including image-guided interventions to prime the tumor microenvironment, and the use of imaging and tissue biomarkers for patient stratification. Altogether, our work aims to establish rational and realistic ways forward towards improving the clinical impact of cancer nanomedicines.

CV:

Twan Lammers obtained a D.Sc. in Radiation Oncology from Heidelberg University in 2008 and a Ph.D. in Pharmaceutical Technology from Utrecht University in 2009. In the same year, he started the Nanomedicine and Theranostics group at RWTH Aachen University. In 2014, he was promoted to full professor of medicine at RWTH Aachen University Clinic. His group aims to individualize and improve disease treatment by combining drug targeting with imaging. To this end, image-guided (theranostic) drug delivery systems are being developed, as well as materials and methods to monitor tumor growth, angiogenesis, inflammation, fibrosis and metastasis. He has received multiple scholarships and awards, including ERC starting, consolidator and proof-of-concept grants, the CRS Young Investigator Award, the Adritelf International Award, the Belgian Society for Pharmaceutical Sciences International Award, and the JNB Trailblazer Award. He has served on the council of the European Society for Molecular Imaging for 10 years ans was the president of the Controlled Release Society in 2023-2024. He is a member of the editorial board of 10 journals, and acts as associate editor for JCR, DDTR and MIB. Since 2019, he is included in the Clarivate Analytics list of Highly Cited Researchers.

Registration:

A registration is needed for this event. Please use the following link: https://us06web.zoom.us/meeting/register/gDFcVJHCRrK7AQ1LkQ05Tg. After the registration you will receive an E-Mail with the log-in details.